# Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008

> **NCT04770194** · PHASE1 · COMPLETED · sponsor: **Shin Poong Pharmaceutical Co. Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Stroke

## Interventions

- **DRUG:** SP-8008 Prototype Capsule A
- **DRUG:** SP-8008 Prototype Capsule B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04770194
- **Lead sponsor:** Shin Poong Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2020-01-23
- **Final completion:** 2020-01-23
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04770194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04770194, "Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04770194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*